These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7907839

  • 1. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM, Lipowski EE.
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [Abstract] [Full Text] [Related]

  • 2. A controlled letter intervention to change prescribing behavior: results of a dual-targeted approach.
    Collins TM, Mott DA, Bigelow WE, Zimmerman DR.
    Health Serv Res; 1997 Oct; 32(4):471-89. PubMed ID: 9327814
    [Abstract] [Full Text] [Related]

  • 3. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK, Kurt TL, Knodel LC, Dean B, Burch C.
    J Am Pharm Assoc (Wash); 2000 Oct; 40(4):495-9. PubMed ID: 10932458
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR, Collins TM, Lipowski EE, Sainfort F.
    Inquiry; 1994 Oct; 31(1):89-101. PubMed ID: 7909535
    [Abstract] [Full Text] [Related]

  • 5. Effect of patient information on the quality of pharmacists' drug use review decisions.
    Warholak-Juarez T, Rupp MT, Salazar TA, Foster S.
    J Am Pharm Assoc (Wash); 2000 Oct; 40(4):500-8. PubMed ID: 10932459
    [Abstract] [Full Text] [Related]

  • 6. Physicians' and pharmacists' perceptions on real-time drug utilization review system: a nationwide survey.
    Lee SM, Lee SO, Kim DS.
    Int J Qual Health Care; 2017 Oct 01; 29(5):634-641. PubMed ID: 28992160
    [Abstract] [Full Text] [Related]

  • 7. Acceptance of pharmacists' suggestions by prescribers: a literature review.
    Klopfer JD, Einarson TR.
    Hosp Pharm; 1990 Sep 01; 25(9):830-2, 834-6. PubMed ID: 10106942
    [Abstract] [Full Text] [Related]

  • 8. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA, Cline RR.
    Med Care; 2002 Aug 01; 40(8):662-74. PubMed ID: 12187180
    [Abstract] [Full Text] [Related]

  • 9. Identification of inappropriate drug prescribing by computerized, retrospective DUR screening in Korea.
    Yeom JH, Park JS, Oh OH, Shin HT, Oh JM.
    Ann Pharmacother; 2005 Nov 01; 39(11):1918-23. PubMed ID: 16219902
    [Abstract] [Full Text] [Related]

  • 10. On-line DUR messages: pharmacists' attitudes and actions in response.
    Armstrong EP, Markson TJ.
    J Am Pharm Assoc (Wash); 1997 Nov 01; NS37(3):315-20. PubMed ID: 9170808
    [Abstract] [Full Text] [Related]

  • 11. How pharmacists respond to on-line, real-time DUR alerts.
    Armstrong EP, Denemark CR.
    J Am Pharm Assoc (Wash); 1998 Nov 01; 38(2):149-54. PubMed ID: 9654846
    [Abstract] [Full Text] [Related]

  • 12. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH, Fassett WE, Christensen DB.
    J Am Pharm Assoc (Wash); 1999 Nov 01; 39(5):650-7. PubMed ID: 10533346
    [Abstract] [Full Text] [Related]

  • 13. Malaria chemoprophylaxis advice: survey of South African community pharmacists' knowledge and practices.
    Toovey S.
    J Travel Med; 2006 Nov 01; 13(3):161-5. PubMed ID: 16706947
    [Abstract] [Full Text] [Related]

  • 14. Response forms reflect pharmacists' participation in retrospective DUR.
    Sleath B, McCament-Mann L, Collins T, Hollarbush J.
    J Am Pharm Assoc (Wash); 1997 Nov 01; NS37(1):77-84. PubMed ID: 9040173
    [Abstract] [Full Text] [Related]

  • 15. Pharmacists' perceptions and practices regarding the purchase of multisource pharmaceuticals.
    Sanborn MD, White SJ.
    Hosp Pharm; 1993 Feb 01; 28(2):104-6, 109-13. PubMed ID: 10125701
    [Abstract] [Full Text] [Related]

  • 16. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R, Grines LL, Pathak DS.
    Am J Hosp Pharm; 1988 Mar 01; 45(3):570-7. PubMed ID: 3369459
    [Abstract] [Full Text] [Related]

  • 17. Drug utilization review using a Medicaid claims database.
    Sena MM, Pashko S.
    Clin Ther; 1993 Mar 01; 15(5):900-4. PubMed ID: 8269457
    [Abstract] [Full Text] [Related]

  • 18. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep 23; 59(184):48811-25. PubMed ID: 10137645
    [Abstract] [Full Text] [Related]

  • 19. PPIs: community pharmacists' perceptions.
    Kaczmarek ER, Stewart JE, Hutchinson RA.
    Contemp Pharm Pract; 1982 Sep 23; 5(3):143-9. PubMed ID: 10256917
    [Abstract] [Full Text] [Related]

  • 20. The ineffectiveness of retrospective drug utilization review.
    Hennessy S, Strom BL.
    LDI Issue Brief; 2003 Sep 23; 9(1):1-4. PubMed ID: 14577443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.